FlorianRudolfSchroeckMDMS

Minimally Invasive Surgery, Surgical Oncology

Section Chief of Urology, White River Junction VA Medical Center, Associate Professor of Surgery Geisel School of Medicine, Dartmouth Cancer Center, and Dartmouth-Hitchcock Medical Center

Join to view full profile

Dr. Schroeck is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Schroeck's full profile

Already have an account?

Office
Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon, NH 03756

Summary

Florian Schroeck, MD, MS, is a urologist based in White River Junction, VT, and Lebanon, NH, with subspecialty training in urologic oncology and health services research. He completed his medical education at Technical University Munich and pursued further training at Duke University and the University of Michigan. Currently, he serves as an Associate Professor at the White River Junction Veterans Affairs Medical Center and at the Geisel School of Medicine at Dartmouth. His expertise includes bladder cancer and urologic oncology, among others. Schroeck has been involved in significant research, publishing on topics such as bladder cancer management and surveillance and conducting clinical trials related to non-muscle-invasive bladder cancer surveillance. His contributions to the field have been recognized with several awards, including a Career Development Award from the Department of Veterans Affairs and best poster awards from the American Urological Association.

Education & Training

University of Michigan Medical CenterFellowship, 2011 - 2014
University of Michigan Medical SchoolMS, Healthcare Research, 2011 - 2012
Duke University HospitalResidency, Urology, 2005 - 2011
Duke University HospitalInternship, Transitional Year, 2005 - 2006
Technical University Munich Faculty of MedicineClass of 2004

Certifications & Licensure

NH State Medical License 2014 - 2026
VT State Medical License 2022 - 2026
MI State Medical License 2010 - 2017
NC State Medical License 2005 - 2011
American Board of Urology Urology

Awards, Honors, & Recognition

Selected by the New England Section of the American Urological Association to represent the region at the “Early Career Investigator Showcase” at the 113th American Urological Association Annual Meeting 2018
Best Poster 112th American Urological Association Annual Meeting, 2017
Career Development Award Department of Veterans Affairs, Veterans Integrated Service Network (VISN), 2015
Career Development Award Conquer Cancer Foundation / American Society of Clinical Oncology, 2015
Dow Career Development Award in Surgery Dartmouth-Hitchcock Medical Center, 2014
Outstanding Poster in Oncology Annual Meeting of the American Urological Association, 2014
First Prize in the Julian Wan Annual Research Award University of Michigan, 2014
First Prize of the Young Urologic Oncologists Society of Urologic Oncology, 2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
First Place Winner Academic Achievement Award Duke University Division of Urology, 2010-2011
Third Place Winner Academic Achievement Award Duke University Division of Urology, 2009
First Place Winner of the Montague Boyd Essay Contest Southeastern section of the AUA, 2009
AUA Gerald P. Murphy Scholar 2008
Distinction in the study of prostate cancer AUA Annual Meeting, 2008
Outstanding Poster Presentation Award Duke Comprehensive Cancer Center annual meeting, 2008
Best poster in the Outcomes / Socioeconomics poster session 87th Annual Meeting of the North Central Section of the AUA
Join now to see all

Clinical Trials

CxBladder Surveillance of Intermediate and High-Risk Bladder Cancer Patients Start of enrollment: 2022 Jun 08
Recruiting
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance Start of enrollment: 2023 Nov 17
Recruiting
Not Applicable

Publications & Presentations

PubMed

Adherence to Synoptic Cancer Pathology Reporting Among Pathologists in the National Department of Veterans Affairs Health Care System.
Abdol Aziz Ould Ismail, Soham Kale, Kathryn McGonagle, Brent Hill, Jason R Pettus
Archives of Pathology & Laboratory Medicine. 2024-11-08
1 citations
The Management of Non-Muscle-Invasive Bladder Cancer in a Veteran Patient Population: Issues and Recommendations.
Jennifer Taylor, Sagar Patel, Krishnanath Gaitonde, Kirsten Greene, Joseph C Liao
Current Oncology. 2024-10-28
Editorial Comment on "Teaching Hospitals and Textbook Outcomes After Major Urologic Cancer Surgery".
Florian R Schroeck
Urology. 2024-09-01

Journal Articles

Implementing risk-aligned bladder cancer surveillance care
Schroeck FR, Smith N, Shelton JB, Urol Oncol, 1/26/2018
Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly
Hollenbeck BK, Kaufman SR, Yan P, Herrel LA, Borza T, Schroeck FR, Jacobs BL, Skolarus TA, Shahinian VB, Eur Urol, 1/1/2018
Impact of Accountable Care Organizations on Diagnostic Testing for Prostate Cancer
Luckenbaugh AN, Hollenbeck BK, Kaufman SR, Yan P, Herrel LA, Skolarus TA, Norton EC, Schroeck FR, Jacobs BL, Miller DC, Hollingsworth JM, Shahinian VB, Borza T, Urology, 1/1/2018
Cost of new Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy, Intensity-modu...
Schroeck FR, Jacobs BL, Bhayani SB, Nguyen PL, Penson D, Hu J, Eur Urol, 1/1/2017
Ensuring Evidence-Based Practice: A Study of Factors Associated with Nonuse of American Urological Association Guidelines
Reinstatler L, Schroeck FR, Hyams ES, Urology Practice, 1/1/2017
Pneumoscrotum With Extensive Penile and Abdominal Subcutaneous Emphysema: A Case Report of Uncertain Etiology
Raffin E, Tundo G, Schroeck F, Urol Case Rep, 1/1/2017
Healthcare integration and quality among men with prostate cancer
Herrel LA, Kaufman SR, Yan P, Miller DC, Schroeck FR, Skolarus TA, Shahinian VB, Hollenbeck BK, J Urol, 1/1/2017
Assembling and validating data from multiple sources to study care for Veterans with bladder cancer
Schroeck FR, Sirovich B, Seigne JD, Robertson DJ, Goodney PP, BMC Urol, 1/1/2017
Development of a Natural Language Processing Engine to Generate Bladder Cancer Pathology Data for Health Services Research
Schroeck FR, Patterson OV, Alba PR, Pattison EA, Seigne JD, DuVall SL, Robertson DJ, Sirovich B, Goodney PP, Urology, 1/1/2017
Early Stage Bladder Cancer - Do Pathology Reports Tell Us What We Need to Know?
Schroeck FR, Pattison EA, Denhalter DW, Patterson OV, DuVall SL, Seigne JD, Robertson DJ, Sirovich B, Goodney PP, Urology, 1/1/2016
Understanding Readmission Intensity After Radical Cystectomy
Skolarus TA, Jacobs BL, Schroeck FR, et al, J. Urol, 1/1/2015
Receipt of "Best Care" According to Current Quality of Care Measures and Outcomes Among men with Prostate Cancer
Schroeck FR, Kaufman SR, Jacobs BL, et al, J. Urol, 1/1/2015
Editorial Comment on: Prebiopsy MRI and MRI-ultrasound Fusion-targeted Prostate Biopsy in Men With Previous Negative Biopsies: Impact on Repeat Biopsy Strategies
Schroeck FR, Sirovich BE, Urology, 1/1/2015
Adherence to Performance Measures and Outcomes among Men Treated for Prostate Cancer
Schroeck FR, Kaufman SR, Jacobs BL, et al, J. Urol, 1/1/2014
Regional Variation in the Quality of Prostate Cancer Care
Schroeck FR, Kaufman SR, Jacobs BL, et al, J. Urol., 1/1/2014
Variation in use of active surveillance among men undergoing expectant management for early-stage prostate cancer
Filson CP, Schroeck FR, Ye Z, Wei JT, Hollenbeck BK, Miller DC, J. Urol., 1/1/2014
Intensity-modulated radiation therapy for prostate cancer: Letter to the editor
Jacobs BL, Schroeck FR, Hollenbeck BK, NEJM, 1/1/2014
Understanding Variation in the Quality of the Surgical Treatment of Prostate Cancer
Schroeck FR, Jacobs BL, Hollenbeck BK, ASCO Educational Book, 1/1/2013
Reply by authors re: Differential adoption of laser prostatectomy for treatment of benign prostatic hyperplasia
Schroeck FR, Wei JT, Urology, 1/1/2013
Certificate of Need Legislation and the Dissemination of Robotic Surgery for Prostate Cancer
Jacobs BL, Zhang Y, Skolarus TA, Wei JT, Montie JE, Schroeck FR, Hollenbeck BK, J. Urol, 1/1/2013
Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy
Schroeck FR, Zuhlke KA, Siddiqui J, et al, J. Urol, 1/1/2013
Editorial comment re: Factors associated with reduction in use of neoadjuvant androgen suppression therapy prior to radical prostatectomy
Schroeck FR, Skolarus TA, Urology, 1/1/2013
Technology Diffusion and Diagnostic Testing for Prostate Cancer
Schroeck FR, Kaufman SR, Jacobs BL, et al, J. Urol, 1/1/2013
Population Based Trends in the Surgical Treatment of Benign Prostatic Hyperplasia
Schroeck FR, Hollingsworth JM, Kaufman SR, et al, J. Urol, 1/1/2012
Are Repeat Prostate Biopsies Safe? A Cohort Analysis From the SEARCH Database
Kopp RP, Stroup SP, Schroeck FR, et al, J. Urol, 1/1/2012
Join now to see all

Books/Book Chapters

Encyclopedia of Quality of Life Research
Chapter: Expanded Prostate Cancer Index Composite (EPIC)
Schroeck FR, Wei JTEditors: Michalos A.Springer2013
The 5-Minute Urology Consult
Chapter: Adenomatoid tumors
Schroeck FR., Moul JWEditors: Gomella LG.Lippincott Williams & WilkinsEdition 2nd,2009
The 5-Minute Urology Consult
Chapter: Medullary cystic kidney disease
Schroeck FR., Moul JWEditors: Gomella LG.Lippincott Williams & WilkinsEdition 2nd,2009
The 5-Minute Urology Consult
Chapter: Umbilical abnormality (drainage and masses)
Schroeck FR., Moul JWEditors: Gomella LG.Lippincott Williams & WilkinsEdition 2nd,2009
Join now to see all

Abstracts/Posters

Overuse of cystoscopic surveillance among patients with non-muscle invasive bladder cancer – a national study of patient, provider, and facility factors
Han DS, Swanton A, Lynch KE, Chang JW, Sirovich B, Robertson DJ, Seigne JD, Goodney PP, Schroeck FR, American Urological Association, San Francisco, CA, 1/1/2018
A national study or risk-aligned surveillance practice for non-muscle invasive bladder cancer
Schroeck FR, Lynch KE, Chang JW, Robertson DJ, Seigne JD, Goodney PP, Sirovich B, American Urological Association, San Francisco, CA, 1/1/2018
Pathology Information Extraction in Bladder Cancer Surveillance
Alba PR, DuVall SL, Workman TE, Schroeck FR, Patterson OV, American Medical Informatics Association (AMIA), Washington, DC, 1/1/2017
Leveraging Big Data to Study Bladder Cancer Care
Schroeck FR, Sirovich B, Seigne JD, Robertson DJ, Goodney PP, New England Section of the American Urological Association, Montreal, CA, 1/1/2017
Harnessing Full Text Pathology Data from the Electronic Health Record to Advance Bladder Cancer Care - Development of a Natural Language Processing System to Generate ...
Schroeck FR, Patterson OV, Alba P, DuVall SL, Sirovich B, Robertson DJ, Seigne JD, Goodney PP, New England Section of the American Urological Association, Montreal, CA, 1/1/2017
Development of a Natural Language Processing Engine to Generate Pathology Data to Advance Bladder Cancer Care
Schroeck FR, Patterson OV, Alba PR, DuVall SL, Sirovich B, Robertson DJ, Seigne JD, Goodney PP, Department of Veterans Affairs HSR&D National Conference, Washington, DC, 1/1/2017
Harnessing full text pathology data from the electronic health record to advance bladder cancer care – Development of a Natural Language Processing system to generate ...
Schroeck FR, Patterson O, Alba P, et al., American Urological Association, Boston, MA, 1/1/2017
The Burden of Cystoscopic Bladder Cancer Surveillance–Anxiety, Discomfort, and Patient Preferences for Decision Making
Koo K, Zubkoff L, Sirovich B, Seigne JD, Goodney PP, Schroeck FR, American Urological Association, Boston, MA, 1/1/2017
Leveraging Big Data to Study Bladder Cancer Care
Schroeck FR, Sirovich B, Seigne JD, Robertson DJ, Goodney PP, American Urological Association, Boston, MA, 1/1/2017
Leveraging Bladder Cancer Pathology Reports for Research: Gleaning Meaning Despite Widely Variable Language
Pattison EA, Denhalter D, Patterson O, DuVall S, Seigne J, Sirovich B, Goodney P, Robertson D, Schroeck FR, American Urological Association, San Diego, 1/1/2016
Surveillance for Bladder Cancer Patients – Do Pathology Reports Tell Us What We Need to Know?
Schroeck FR, Pattison EA, Denhalter D, et al., American Urological Association, San Diego, 1/1/2016
The Burden of Cystoscopic Bladder Cancer Surveillance–Anxiety, Discomfort, and Patient Preferences for Decision Making
Koo K, Zubkoff L, Sirovich BE, Seigne JD, Goodney PP, Schroeck FR, 17th Annual Meeting of the Society of Urologic Oncology, San Antonio, 1/1/2016
Do Prostate Cancer Patients Receiving the “Best Care” have Better Outcomes?
Schroeck FR, Kaufman SR, Jacobs BL, Skolarus TA, Miller DC, Suskind AM, Hollenbeck BK, American Urological Association, Orlando, 1/1/2014
Healthcare System Quality and Outcomes among Men Treated for Prostate Cancer
Schroeck FR, Kaufman SR, Jacobs BL, Skolarus TA, Miller DC, Suskind AM, Hollenbeck BK, American Urological Association, Orlando, 1/1/2014
Physician use of sacral neuromodulation in Medicare beneficiaries; Are physicians who are high testers also high implanters?
Suskind AM, Clemens JQ, Zhang Y, Schroeck FR, Hollenbeck BK, American Urological Association, Orlando, 1/1/2014
Comparative effectiveness of sling surgery in Medicare beneficiaries
Suskind AM, Clemens JQ, Dunn RL, Hollingsworth JM, Yun Z, Jacobs BL, Schroeck FR, Hollenbeck BK, American Urological Association, San Diego, 1/1/2013
Assessing the intended effects of ambulatory surgery centers on the delivery of outpatient urologic procedures
Suskind AM, Dunn RL, Yun Z, Hollingsworth JM, Jacobs BL, Schroeck FR, Hollenbeck BK, American Urological Association, San Diego, 1/1/2013
The dissemination of intensity-modulated radiotherapy and robotic prostatectomy among men at low risk of dying from prostate cancer
Jacobs BL, Zhang Y, Schroeck FR, Skolarus TA, Suskind AM, Weizer AZ, Montgomery JS, Wei JT, Montie JE, Hollingsworth JM, Miller DC, Hollenbeck BK, American Urological Association, San Diego, 1/1/2013
Technology and Prostate Cancer Quality of Care
Schroeck FR, Kaufman SR, Jacobs BL, Skolarus TA, Miller DC, Suskind AM, Hollenbeck BK, American Urological Association, San Diego, 1/1/2013
Regional Variation in the Quality of Prostate Cancer Care
Schroeck FR, Kaufman SR, Jacobs BL, Skolarus TA, Hollingsworth JM, Miller DC, Suskind AM, Hollenbeck BK, American Urological Association, San Diego, 1/1/2013
The Impact of Technology Diffusion on Treatment for Prostate Cancer
Schroeck FR, Kaufman SR, Jacobs BL, Miller DC, Hollenbeck BK, ASCO Annual Meeting, Chicago, 1/1/2013
Assessing the intended effects of ambulatory surgery centers on the delivery of outpatient procedures
Suskind AM, Dunn RL, Zhang Y, Hollingsworth JM, Jacobs BL, Schroeck FR, Hollenbeck BK, Academy Health Annual Meeting, Baltimore, 1/1/2013
Regional Variation in the Quality of Prostate Cancer Care
Schroeck FR, Kaufman SR, Jacobs BL, Skolarus TA, Hollingsworth JM, Miller DC, Suskind AM, Hollenbeck BK, Academy Health Annual Meeting, Baltimore, 1/1/2013
Quality of outpatient sling surgery for urinary incontinence in Medicare beneficiaries
Suskind AM, Clemens JQ, Dunn RL, Zhang Y, Stoffel JT, Schroeck FR, Jacobs BL, Hollenbeck BK, North Central Section of the American Urological Association, Naples, FL, 1/1/2013
Technology Diffusion and Diagnostic Testing for Prostate Cancer
Schroeck FR, Kaufman SR, Jacobs BL, Skolarus TA, Miller DC, Suskind AM, Hollenbeck BK, North Central Section of the American Urological Association, Naples, FL, 1/1/2013
Join now to see all

Lectures

Using data and implementation science to improve bladder cancer care within VA
Washington University, St. Louis, MO - 1/9/2017
Leveraging "Big Data" to Advance Bladder Cancer Care
Technische Universität München, Munich, Germany, 2016; Dartmouth Hitchcock Medical Center, Lebanon, - 1/28/2016
Leveraging Full Text Pathology Data to Improve Bladder Cancer Care
Dartmouth Hitchcock Medical Center, Lebanon, NH - 1/1/2016
Towards risk-aligned care for patients with early stage bladder cancer
Dartmouth Hitchcock Medical Center, Lebanon, NH - 1/27/2015
The Impact of Technology on the Quantity and Quality of Prostate Cancer Care
Burlington, VT - 1/2/2015
The Impact of Technology Diffusion on the Quantity and Quality of Prostate Cancer Care
University of Rochester, Rochester, NY, 2013; Emory University, Atlanta, GA, 2013 - 1/21/2013
The Impact of Technology on Prostate Cancer Quality of Care
Ann Arbor, MI - 1/18/2013
The Impact of Technology on Prostate Cancer Care
Ann Arbor, MI - 1/5/2012
Evidence Based Research on Open vs. Robotic Approaches
Durham, NC, 2008, 2009 - 1/9/2009
Join now to see all

Authored Content

Implementing Risk-Aligned Bladder Cancer Surveillance Care☆February 2018
Implementing Risk-Aligned Bladder Cancer Surveillance Care☆February 2018

Press Mentions

Florian Schroeck, MD, MS, on Risk-Aligned Bladder Cancer SurveillanceSeptember 29th, 2022
'Every Patient Would Applaud' Bladder Cancer Surveillance StudyMay 23rd, 2020
Bladder Cancer Surveillance Study "All Patients Would Applaud"May 22nd, 2020